MedTrace Logo

Systemic Therapy and Cognitive Behavioral Therapy for Social Anxiety Disorders

NCT02360033 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2019-10-18

No results posted yet for this study

Summary

Goals of the study:

Systemic Therapy was approved in 2008 by the Scientific Advisory Board on Psychotherapy (Wissenschaftlicher Beirat Psychotherapie: WBP) for a variety of disorders which, at the time, did not include anxiety disorders. According to the 2007 joint methods paper of the WBP and the Mutual Federal Committee (Gemeinsamen Bundesausschuss: G-Ba), there must be three randomized-controlled trials (RCT) for anxiety disorders. These studies are available now but lack explicit details about the clinical significance of the reductions they show in social anxiety symptoms. This project is funded by the German Association for Systemic Therapy, Counseling and Family Therapy (Deutsche Gesellschaft für Systemische Therapie, Beratung und Familientherapie: DGSF).

Study design:

The study is planned as a mono-centric, balanced pilot RCT. It investigates the feasibility of an RCT comparing Systemic Therapy and Cognitive Behavioral Therapy for Social Anxiety Disorders (SAD) in 32 patients.

Conditions

Interventions

BEHAVIORAL

Systemic Therapy for Social Anxiety Disorder

BEHAVIORAL

Cognitive Behavioral Therapy for Social Anxiety Disorder

Sponsors & Collaborators

  • German Association for Systemic Therapy, Counseling and Family Therapy (DGSF)

    collaborator UNKNOWN

  • Systemic Society (SG)

    collaborator UNKNOWN

  • Heidehof Foundation

    collaborator UNKNOWN

  • Heidelberg University

    lead OTHER

Principal Investigators

  • Christina Hunger, Dr. · Institute of Medical Psychology, University Hospital Heidelberg/Germany

  • Jochen Schweitzer, Prof. Dr. · Institute of Medical Psychology, University Hospital Heidelberg/Germany

  • Hinrich Bents, Dr. · Centre for Psychological Psychotherapy Heidelberg (ZPP)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2017-01-31
Completion
2017-09-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02360033 on ClinicalTrials.gov